Sci-Tech Today Bhutan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Today Bhutan.

Press releases published on May 4, 2026

May 4, 2026

Axiant Launches with Innovative Process-First Methodology to Address Automation Failures

Indeterminate GlobeNewswire

May 4, 2026

Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study

Indeterminate GlobeNewswire

May 4, 2026

Edgesource Corporation Acquires Lyteworx Automation Systems, Deepening Its Defense and Intelligence Mission Capabilities

Indeterminate GlobeNewswire

May 4, 2026

New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC

Indeterminate GlobeNewswire

May 4, 2026

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 4, 2026

Teva to Present at the BofA Securities Health Care Conference

Indeterminate GlobeNewswire

May 4, 2026

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 4, 2026

Cellectis publiera ses résultats financiers du premier trimestre le 11 mai 2026

Indeterminate GlobeNewswire

May 4, 2026

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 4, 2026

Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026

Indeterminate GlobeNewswire

May 4, 2026

BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026

Indeterminate GlobeNewswire

May 4, 2026

Kyntra Bio to Report First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 4, 2026

Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 4, 2026

Clip Money Inc. Announces Amendment of Unsecured Convertible Notes

Indeterminate GlobeNewswire

May 4, 2026

Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12

Indeterminate GlobeNewswire

May 4, 2026

Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital

Indeterminate GlobeNewswire

May 4, 2026

Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Indeterminate GlobeNewswire

May 4, 2026

ORIC® Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Updates

Indeterminate GlobeNewswire

May 4, 2026

Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes

Indeterminate GlobeNewswire

May 4, 2026

Biodesix Announces First Quarter 2026 Results and Highlights

Indeterminate GlobeNewswire